PHB1 and urea cycle disorder: Interestingly, although PhB is approved for the treatment of certain metabolism-associated diseases (e.g., urea cycle disorders), the impact of this drug with respect to typical cancer-associated metabolic changes such as the Warburg effect is widely unexplored.